Systemic Lupus Erythematosus
Henry Ford Health System – Rheumatology Primary Coordinator: Jenna Hudy 313-916-9328 Indication: Systemic Lupus Erythematosus Enrollment Status: Open Protocol: CVAY736F12301 Drug: Ianalumab Sponsor: Novartis Description: A randomized, double-blind, parallel group, placebo-controlled multicenter phase 3 study to […]
Vasculitis
Henry Ford Health System – Rheumatology Primary Coordinator: Jenna Hudy 313-916-9328 Indication: Vasculitis Enrollment Status: Open Protocol: 20220159 Drug: Avacopan Sponsor: Amgen Description: A randomized, double-blind, placebo-controlled phase 4 clinical trial to evaluate the […]
Sjogren’s Syndrome
Clinical Research Institute of Michigan – Shores Rheumatology Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201 Indication: Sjogren’s Syndrome Enrollment Status: Open Protocol: HZNP-DAZ-301, HZNP-DAZ-301 HZNP-DAZ-304 “Oasis” Drug: Dazodalibep Sponsor: Horizon/Amgen […]